Pharmafile Logo

Webinar: Ensuring an actionable segmentation

March 31, 2015 |  

One of the most consistent issues researchers face with segmentation is ensuring that it is actionable.

One of the most consistent issues researchers face with segmentation is ensuring that it is actionable. Even the best constructed and well observed segmentation solution will fall down if people within your company don’t adopt it, and the most detailed and comprehensive (and expensive) segmentation is of no use if it isn’t implemented.

In this webinar, quantitative experts Duncan Munro and Jennifer Redfearn, utilise knowledge and experience garnered from more than 15 years of conducting global segmentations for pharma, to explore the following key segmentation challenges:

  • Conducting global segmentations
    The benefits and potential pitfalls of conducting global segmentation research
  • Encouraging internal buy-in
    Examining the best techniques to ensure that a segmentation is adopted by key internal stakeholders.
  • Ensuring sales force execution
    Identifying the key challenges that prevent successful execution and explore the ways in which researchers can overcome these issues and ensure an actionable segmentation   
  • Answer your segmentation questions

To view this webinar please visit http://bit.ly/1C4QKwL

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Infographic: Are data blind spots putting your launch at risk?

Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with fragmented data spread across multiple systems, making it difficult to understand market readiness, prioritize…

Key takeaways from ASCO® 2026

Following ASCO® 2026, Inizio’s experts have shared their perspectives across three thought leadership articles, each exploring a different aspect of what this year’s congress revealed for pharmaceutical organisations. Together, they…

Webcast | Smarter science, sharper strategy: Expert perspectives from ASCO® 2026

Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.

From activity to impact: 5 takeaways from MAPS Americas 2026

Across sessions, panels, and conversations on the ground in Denver, there was a noticeable shift in both mindset and momentum. Many of the themes discussed in previous years are now…

Inizio launches Intelligent Congress: Turning medical event investment into measurable impact

Inizio, the global commercialization partner to the health and life sciences industry, today announced the launch of Intelligent Congress – a connected, end-to-end solution designed to help pharma organizations maximize…

Inizio Unveils Next-Generation Hub Services at Asembia 2026, Setting a New Standard in Patient Access

Integrated capabilities combining advanced analytics, pharmacy, and specialized talent to improve access, affordability, and adherence

5 takeaways from Reuters’ Pharma USA 2026 – and what they mean for you

Pharma USA is North America’s largest cross-functional pharma event and Inizio was there to offer insights on patient engagement, accelerated product launches, and Intelligent Commercializationâ„¢. Now we’re back in the…

Precision Medical Affairs in Action: Using AI and Analytics to Elevate Strategy, Engagement, and Impact

Discover how AI, analytics and real-world data are reshaping Medical Affairs.

How did multifaceted support from across Inizio help a biotech firm prepare for launch?

Discover how teams from across Inizio provided a range of integrated services to give a client’s product the best chance of launch success.

Our key takeaways from ISMPP EU 2026 – Evolving with Purpose: Excellence in an Era of Efficiency

Explore Inizio Medical’s key takeaway from ISMPP EU 2026, including AI governance, transparency, patient partnership and evolving impact measurement.